Pechumer H, Leinisch E, Bender-Götze C, Ziegler-Heitbrock H W
Pediatric Outpatient Clinic, University of Munich, Germany.
Transplantation. 1991 Oct;52(4):698-704. doi: 10.1097/00007890-199110000-00022.
After bone marrow transplantation many T-lymphocyte functions, including the production of cytokines (CK), such as interleukin 2, are severely depressed for months. The monocyte-derived cytokines tumor necrosis factor alpha and interleukin 6 are molecules central to immune functions. Moreover, they may be involved in graft-versus-host disease and in graft-versus-leukemia reaction. Hence, we have studied the reappearance of these CKs after BMT by analyzing whole blood cultures stimulated in vitro with lipopolysaccharide for 6 hr, followed by testing for the secretion of TNF in the WEHI 164/actinomycin D cytotoxicity bioassay and for IL-6 in the 7 TD 1 proliferation assay. We performed sequential studies in 6 children who were transplanted for aplastic anemia or leukemia with allogeneic bone marrow. We found that the production of both CKs can be induced as early as 10-14 days post BMT at the very beginning of engraftment, indicating that the regenerating monocyte system is recovering rapidly after BMT. Depletion and neutralization experiments confirmed that monocytes are the cellular source of the LPS-induced CK secretion after BMT. Control levels were reached 3 to 4 weeks post BMT. When analyzing the endotoxin-induced CK production in a larger panel of BMT patients after complete reconstitution, we could not detect any impact of acute or chronic GvHD, or of allogeneic or autologous BMT, nor did treatment with cyclosporine A (CsA) show any suppressive effect. Thus, our data show that the CK production of the monocyte/macrophage lineage is quite resistant to factors that do influence other cell lineages of the immune system during BMT. The coincident appearance of monocyte-derived cytokines and of GvHD suggests a role for these cytokines in GvHD in man.
骨髓移植后,许多T淋巴细胞功能,包括细胞因子(CK)如白细胞介素2的产生,会在数月内严重受抑。单核细胞衍生的细胞因子肿瘤坏死因子α和白细胞介素6是免疫功能的核心分子。此外,它们可能参与移植物抗宿主病和移植物抗白血病反应。因此,我们通过分析用脂多糖体外刺激6小时后的全血培养物,随后在WEHI 164/放线菌素D细胞毒性生物测定中检测肿瘤坏死因子(TNF)的分泌以及在7 TD 1增殖测定中检测白细胞介素6(IL-6)的分泌,来研究骨髓移植后这些细胞因子的再现情况。我们对6名因再生障碍性贫血或白血病接受异基因骨髓移植的儿童进行了连续研究。我们发现,早在骨髓移植后10 - 14天植入开始时,这两种细胞因子的产生就能被诱导,这表明骨髓移植后再生的单核细胞系统恢复迅速。去除和中和实验证实,单核细胞是骨髓移植后脂多糖诱导的细胞因子分泌的细胞来源。骨髓移植后3至4周达到对照水平。在对一大组完全重建后的骨髓移植患者进行内毒素诱导的细胞因子产生分析时,我们未检测到急性或慢性移植物抗宿主病、异基因或自体骨髓移植有任何影响,用环孢素A(CsA)治疗也未显示出任何抑制作用。因此,我们的数据表明,单核细胞/巨噬细胞谱系的细胞因子产生对骨髓移植期间确实影响免疫系统其他细胞谱系的因素具有相当的抗性。单核细胞衍生的细胞因子与移植物抗宿主病同时出现,提示这些细胞因子在人类移植物抗宿主病中发挥作用。